Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-11-13
1991-08-06
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544284, 544285, 544286, A61K 31505, C07D23980
Patent
active
050378295
ABSTRACT:
(1H-azol-1-ylmethyl)substituted quinazoline derivatives, compositions containing the same, and methods of treating mammals suffering from disorders which are characterized by an increased proliferation and/or abnormal differentiation of epithelial tissues.
REFERENCES:
patent: 2943574 (1990-07-01), Raeymaekers et al.
patent: 3890319 (1975-06-01), Danielewicz et al.
patent: 4532250 (1985-07-01), Stout et al.
patent: 4859684 (1989-08-01), Raeymaekers et al.
Freyne Eddy J. E.
Raeymaekers Alfons H. M.
Sanz Gerard C.
Venet Marc G.
Ivy C. Warren
Janssen Pharmaceutica N.V.
Metz Charles J.
Turnipseed James H.
LandOfFree
(1H-azol-1-ylmethyl) substituted quinazoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (1H-azol-1-ylmethyl) substituted quinazoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (1H-azol-1-ylmethyl) substituted quinazoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1987262